{
    "clinical_study": {
        "@rank": "102776", 
        "brief_summary": {
            "textblock": "The purpose of this study is to learn if aripiprazole is effective in the treatment of a\n      large number of persons diagnosed with schizophrenia or schizoaffective disorders"
        }, 
        "brief_title": "Broad Effectiveness: Study With Aripiprazole", 
        "completion_date": {
            "#text": "January 2003", 
            "@type": "Actual"
        }, 
        "condition": [
            "Schizophrenia", 
            "Schizoaffective Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Psychotic Disorders", 
                "Schizophrenia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Patients with Schizophrenia or Schizoaffective Disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "444", 
        "firstreceived_date": "May 8, 2002", 
        "id_info": {
            "nct_id": "NCT00036361", 
            "org_study_id": "CN138-087"
        }, 
        "intervention": {
            "intervention_name": "Aripiprazole", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Aripiprazole"
        }, 
        "lastchanged_date": "November 7, 2013", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Wallingford", 
                    "country": "United States", 
                    "state": "Connecticut"
                }, 
                "name": "Local Institution"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Broad Effectiveness: Study With Aripiprazole", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2003", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Safety Assessments"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00036361"
        }, 
        "secondary_outcome": {
            "measure": "Safety Assessments"
        }, 
        "source": "Otsuka Pharmaceutical Development & Commercialization, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Otsuka America Pharmaceutical", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Otsuka Pharmaceutical Development & Commercialization, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2002", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2007"
    }, 
    "geocoordinates": {
        "Local Institution": "41.457 -72.823"
    }
}